Back
Relmada Therapeutics Vs. Cyclacel Pharmaceuticals Industry Stock Comparison
Sell
25
RLMD
Relmada Therapeutics
Last Price:
3.35
Seasonality Move:
-10.66%
Sell
47
CYCC
Cyclacel Pharmaceuticals
Last Price:
2.29
Seasonality Move:
-13.89%
Sell
25
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
- The current Relmada Therapeutics [RLMD] share price is $3.34. The Score for RLMD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?
- The current Cyclacel Pharmaceuticals [CYCC] share price is $2.29. The Score for CYCC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- CYCC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $3.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing selling pressure, which indicates risk of future bearish movement.
CYCC Stock Price Chart
What is Cyclacel Pharmaceuticals's stock price today?
-
The Cyclacel Pharmaceuticals share price today is $2.29
The current trend is moderately bullish and CYCC is experiencing slight selling pressure.
RLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 32.15 | Sell |
Chaikin Money Flow: | -36523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.5 - 4.16) | Sell |
Bollinger Bands (100): | (3.57 - 5.47) | Sell |
CYCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 51.56 | Buy |
Chaikin Money Flow: | -9645 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.7 - 2.46) | Buy |
Bollinger Bands (100): | (1.97 - 2.69) | Sell |
RLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.58 | Sell |
20-day SMA: | 3.69 | Sell |
50-day SMA: | 4.41 | Sell |
200-day SMA: | 3.76 | Sell |
8-day EMA: | 3.55 | Sell |
20-day EMA: | 3.77 | Sell |
50-day EMA: | 4.17 | Sell |
200-day EMA: | 4.36 | Sell |
CYCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.42 | Sell |
20-day SMA: | 2.16 | Buy |
50-day SMA: | 2.15 | Buy |
200-day SMA: | 4.25 | Sell |
8-day EMA: | 2.37 | Sell |
20-day EMA: | 2.24 | Buy |
50-day EMA: | 2.26 | Buy |
200-day EMA: | 4.67 | Sell |
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.
Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.67 per share, and an increase next year of $1.36 per share.
Relmada Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cyclacel Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |